NIBSC - 20th SoGAT Meeting

Enter a search term

Home Page > Spotlight > Standardisation of Genome Amplification Techniques > Blood virology > Past meetings > 20th SoGAT Meeting

20th SoGAT Meeting

Return to previous page|

SoGAT XX Presentations

Speaker	Title of Talk	Presentation
Session 1: Standardisation science Part 1
Sally Baylis, NIBSC, UK	HCV IS study	View Presentation
Harvey Holmes, NIBSC, UK	Plans for 2nd reference panel for HIV-1 genotypes and HIV-2 IS	View Presentation
Indira Hewlett, FDA, USA	Update from CBER	View Presentation
Micha Nübling, Paul- Ehrlich Institute, Germany	Update on WHO projects including anti-HBc	View Presentation
Roberta Madej, Roche, USA	HCV synthetic calibrator study	View Presentation
Session 2: Standardisation science Part 2
Michael Chudy, WHO, Switzerland	WHO strategic plan for the development of Biological Reference Preparations for blood safety-related IVDs	View Presentation
Ralf Schönbrunner, Acrometrix, USA	Practical aspects of standardization for a global controls manufacturer	View Presentation
Mark Manak, SeraCare, USA	Preparation of HIV, HBV and HCV NAT controls: Formulation, Stability and Performance	View Presentation
Saeko Mizusawa, Yoshiaki Okada, National Institute of Infectious Diseases, Japan	Establishment of national standards for NAT blood viruses and NAT proficiency program in Japan	View Presentation
Neil Berry, NIBSC, UK	Quantification of SIV RNA and evaluation of infectivity	View Presentation
Cindy Walker-Peach, Asuragen Inc., USA	Towards NAT testing in solid tissues and organs: a pre-analytical solution for nucleic acid stabilization	View Presentation
Session 3: EQAS and proficiency studies
Heinz Zeichhardt, Hans-Peter Grunert, Institut fuer Infektionsmedizin, Germany	EQAS for TTI diagnostics as tool for elucidating and solving problems of commercial and in-house tests	View Presentation
Wayne Dimech, Thu-Anh Pham, Darren Jardine, Elizabeth Dax , National Serology Reference Laboratory, Australia	Monitoring the performance of nucleic acid tests using data generated from EDCNet and DigitalPT	View Presentation
Session 4: Parvovirus B19
Mei-ying Yu, FDA, USA	Parvovirus B19 Transmission in transfusion recipients as assessed in a prospective study (TRIPS)	View Presentation
Yi-Chen Yang, Bureau of Food and Drug Analysis, Taiwan	Collaborative study for establishment of the first national standard for Parvovirus B19 DNA NAT assays	View Presentation
Jacqueline Fryer, NIBSC, UK	Human PARV4 in clotting factor VIII concentrates	View Presentation
Lori Rincknel, Talecris Biotheraputics, USA	Identification of novel parvovirus B19 variants	View Presentation
Session 5: Virus variability and HBV
If Barnes, Daniel Candotti, Jean-Pierre Allain, East Anglia Blood Centre, UK	Viral load distribution, BCP/PC mutations and HBV genotypes	View Presentation
Kiyoko Nojima Umemori, Yoshiaki Okada, NIH, Japan	Preparation of plasmids containing HBV-full genome of genotype A to H and trial of HBV inactivation method	View Presentation
Piotr Grabarczk, Ewa Brojer, Institute of Haematology and Transfusion Medicine, Poland	Anti HBc-detection in ULTRIO not-repeatable reactive blood donors	View Presentation
Hiroshi Yoshizawa, Keiko Katayama, Junko Tanaka, Hiroshima University, Japan	Minimum infectious dose of HBV required for establishing infection to human hepatocyte transplanted chimera mice	View Presentation
Michael Chudy, Indira Hewlett, Micha Nübling, Kurt Roth, Peter Simmonds	Panel discussion: Impact of virus variability (genotypes) on NAT	View Presentation
Session 6: CMV standardisation and detection
Jutta Preiksaitis, Provlab, Canada	Development of an International Standard for EBV and CMV quantitative viral load assessment	View Presentation
Marcia Holden, NIST, USA	NIST Standard Reference Material Project: Pure DNA Standard for Cytomegalovirus	View Presentation
Vivienne James, HPA, UK	Update on UK NEQAS external quality assessment for HCV RNA and CMV DNA	View Presentation
Lara Compston, Daniel Candotti, Jean-Pierre Allain, East Anglia Blood Centre, UK	Detection and quantification of herpesviruses (CMV, EBV, VZV) and NA viruses (GBV-C, HAV) by Multiplex	View Presentation
Albrecht Groner	Round table discussion on IUs vs copies/geqs and conversion factors. Presenters to give pros and cons of using IUs and the appropriateness of converting between IUs and copies	View Presentation
Session 7: NAT new technologies/performance of current technology
Peter Vallone, NIST, USA	Developing multiplex PCR assays for human identity testing - is there overlap with pathogen screening?	View Presentation
Lutz Pichl, V Schottstedt, German Red Cross Blood Transfusion Service West, Hagen, Germany	Evaluation data on the new Roche COBAS S201 system in combination with the COBAS TaqScreen MPX test	View Presentation
Yiu-Lian Fong, Novartis Vaccines and Diagnostics, USA	Performance of Chiron Quantitative and Qualitative HBV PCR and confirmation of HBV Yield Cases	View Presentation
Philip Tuke, UCL, UK	HCV window phase infections: Closing the window on HCV. A comparison of two combined antigen/antibody assays with QRT-PCR	View Presentation
Sally Baylis/Philip Minor, NIBSC, UK	NAT standards for clinical virology	View Presentation
Stephen Inglis, NIBSC, UK	Future SoGAT meetings and closing remarks	View Presentation

20th SoGAT Meeting

SoGAT XX Presentations

Speaker

Title of Talk

Presentation